Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Phototherapy | 19 | 2022 | 368 | 6.470 |
Why?
|
Wound Infection | 14 | 2020 | 244 | 4.310 |
Why?
|
Light | 24 | 2024 | 1358 | 4.100 |
Why?
|
Photochemotherapy | 31 | 2022 | 828 | 3.470 |
Why?
|
Acinetobacter baumannii | 11 | 2021 | 125 | 3.120 |
Why?
|
Photosensitizing Agents | 24 | 2022 | 627 | 2.930 |
Why?
|
Burns | 18 | 2023 | 1902 | 2.570 |
Why?
|
Anti-Infective Agents | 16 | 2023 | 987 | 2.480 |
Why?
|
Ultraviolet Therapy | 6 | 2020 | 82 | 2.410 |
Why?
|
Candida albicans | 7 | 2019 | 377 | 2.150 |
Why?
|
Pseudomonas aeruginosa | 14 | 2024 | 1276 | 2.140 |
Why?
|
Quinine | 3 | 2021 | 51 | 2.120 |
Why?
|
Acinetobacter Infections | 7 | 2020 | 74 | 2.120 |
Why?
|
Methicillin-Resistant Staphylococcus aureus | 13 | 2022 | 705 | 1.980 |
Why?
|
Candidiasis | 5 | 2019 | 372 | 1.760 |
Why?
|
Biofilms | 11 | 2024 | 641 | 1.690 |
Why?
|
Porphyrins | 5 | 2021 | 352 | 1.530 |
Why?
|
Pseudomonas Infections | 6 | 2020 | 622 | 1.400 |
Why?
|
Ultraviolet Rays | 7 | 2020 | 1101 | 1.260 |
Why?
|
Anti-Bacterial Agents | 19 | 2024 | 7475 | 1.210 |
Why?
|
Neisseria gonorrhoeae | 3 | 2019 | 249 | 1.200 |
Why?
|
Disinfection | 4 | 2020 | 207 | 1.160 |
Why?
|
Fungi | 6 | 2017 | 346 | 1.080 |
Why?
|
Staphylococcal Skin Infections | 3 | 2020 | 78 | 1.080 |
Why?
|
Bacterial Infections | 11 | 2021 | 1390 | 1.060 |
Why?
|
Mice, Inbred BALB C | 27 | 2020 | 6222 | 0.980 |
Why?
|
Chitosan | 5 | 2012 | 138 | 0.880 |
Why?
|
Mycoses | 5 | 2017 | 389 | 0.820 |
Why?
|
Microbial Viability | 3 | 2021 | 236 | 0.790 |
Why?
|
Gram-Negative Bacterial Infections | 2 | 2016 | 239 | 0.750 |
Why?
|
Pyocyanine | 1 | 2021 | 20 | 0.740 |
Why?
|
Drug Resistance, Multiple, Bacterial | 5 | 2020 | 592 | 0.740 |
Why?
|
Skin Diseases, Infectious | 1 | 2021 | 75 | 0.740 |
Why?
|
Reactive Oxygen Species | 9 | 2024 | 2142 | 0.730 |
Why?
|
Bacteria | 7 | 2023 | 2212 | 0.710 |
Why?
|
Aspergillus fumigatus | 1 | 2021 | 158 | 0.690 |
Why?
|
Microbial Sensitivity Tests | 12 | 2024 | 1972 | 0.680 |
Why?
|
Keratinocytes | 5 | 2016 | 876 | 0.670 |
Why?
|
Bacterial Load | 1 | 2019 | 155 | 0.630 |
Why?
|
Drug Resistance, Bacterial | 3 | 2021 | 1065 | 0.630 |
Why?
|
Gram-Positive Bacterial Infections | 2 | 2012 | 340 | 0.630 |
Why?
|
Patents as Topic | 2 | 2018 | 112 | 0.610 |
Why?
|
Otitis Media | 1 | 2020 | 287 | 0.580 |
Why?
|
Fullerenes | 5 | 2015 | 14 | 0.530 |
Why?
|
Communicable Diseases | 2 | 2023 | 872 | 0.520 |
Why?
|
Skin Diseases, Bacterial | 2 | 2016 | 65 | 0.520 |
Why?
|
Drug Resistance, Multiple | 3 | 2021 | 255 | 0.500 |
Why?
|
Wound Healing | 8 | 2017 | 2800 | 0.500 |
Why?
|
Mice | 43 | 2023 | 81889 | 0.490 |
Why?
|
Skin | 8 | 2021 | 4499 | 0.490 |
Why?
|
Gonorrhea | 1 | 2019 | 355 | 0.480 |
Why?
|
Drug Resistance, Microbial | 6 | 2021 | 832 | 0.470 |
Why?
|
Animals | 56 | 2023 | 168930 | 0.460 |
Why?
|
Propionibacterium acnes | 2 | 2021 | 59 | 0.450 |
Why?
|
Disease Models, Animal | 17 | 2020 | 18330 | 0.450 |
Why?
|
Eye Infections, Bacterial | 1 | 2017 | 239 | 0.440 |
Why?
|
Bandages | 3 | 2012 | 270 | 0.440 |
Why?
|
Keratitis | 1 | 2017 | 241 | 0.440 |
Why?
|
Antimalarials | 1 | 2019 | 909 | 0.410 |
Why?
|
Candidiasis, Cutaneous | 1 | 2011 | 6 | 0.390 |
Why?
|
Staphylococcal Infections | 5 | 2017 | 1396 | 0.380 |
Why?
|
Cornea | 2 | 2017 | 1316 | 0.380 |
Why?
|
Cryotherapy | 3 | 2006 | 164 | 0.360 |
Why?
|
Oxygen | 2 | 2019 | 4251 | 0.360 |
Why?
|
Coloring Agents | 2 | 2011 | 565 | 0.330 |
Why?
|
Telangiectasis | 3 | 2007 | 78 | 0.320 |
Why?
|
Wounds, Penetrating | 1 | 2011 | 316 | 0.310 |
Why?
|
Helicobacter pylori | 1 | 2012 | 380 | 0.310 |
Why?
|
Helicobacter Infections | 1 | 2012 | 390 | 0.310 |
Why?
|
Laser Therapy | 5 | 2011 | 1108 | 0.310 |
Why?
|
Arthrodermataceae | 1 | 2008 | 7 | 0.310 |
Why?
|
Tolonium Chloride | 4 | 2012 | 23 | 0.310 |
Why?
|
Methylene Blue | 4 | 2013 | 156 | 0.300 |
Why?
|
Hot Temperature | 3 | 2011 | 1442 | 0.300 |
Why?
|
Dermatomycoses | 1 | 2008 | 45 | 0.300 |
Why?
|
Onychomycosis | 1 | 2008 | 50 | 0.290 |
Why?
|
Anti-Infective Agents, Local | 1 | 2010 | 246 | 0.290 |
Why?
|
Radiation-Sensitizing Agents | 1 | 2010 | 348 | 0.290 |
Why?
|
Rabbits | 5 | 2017 | 4752 | 0.290 |
Why?
|
Colony Count, Microbial | 2 | 2019 | 326 | 0.290 |
Why?
|
Administration, Topical | 4 | 2011 | 702 | 0.290 |
Why?
|
Infrared Rays | 3 | 2020 | 246 | 0.280 |
Why?
|
Dose-Response Relationship, Radiation | 5 | 2012 | 877 | 0.280 |
Why?
|
Acne Vulgaris | 1 | 2012 | 352 | 0.270 |
Why?
|
Antifungal Agents | 2 | 2011 | 769 | 0.270 |
Why?
|
Hydrocarbons, Fluorinated | 1 | 2006 | 40 | 0.270 |
Why?
|
Enterococcus faecalis | 3 | 2019 | 244 | 0.250 |
Why?
|
Catheterization, Central Venous | 1 | 2010 | 538 | 0.250 |
Why?
|
Proteus mirabilis | 2 | 2019 | 24 | 0.250 |
Why?
|
Silver | 3 | 2011 | 119 | 0.240 |
Why?
|
Ceftazidime | 2 | 2024 | 57 | 0.240 |
Why?
|
Chloramphenicol | 1 | 2023 | 67 | 0.220 |
Why?
|
Antimicrobial Cationic Peptides | 2 | 2020 | 350 | 0.220 |
Why?
|
beta-Lactam Resistance | 1 | 2024 | 79 | 0.220 |
Why?
|
Escherichia coli | 6 | 2024 | 4211 | 0.220 |
Why?
|
Hydroxyl Radical | 1 | 2023 | 81 | 0.220 |
Why?
|
Epidermis | 2 | 2005 | 540 | 0.220 |
Why?
|
Infection Control | 1 | 2010 | 984 | 0.210 |
Why?
|
Lasers | 2 | 2011 | 951 | 0.210 |
Why?
|
Microscopy, Electron, Transmission | 2 | 2016 | 684 | 0.210 |
Why?
|
Blood Vessels | 2 | 2005 | 1111 | 0.210 |
Why?
|
Laser Coagulation | 1 | 2004 | 335 | 0.200 |
Why?
|
Culture Media | 1 | 2024 | 893 | 0.200 |
Why?
|
Klebsiella pneumoniae | 1 | 2024 | 253 | 0.200 |
Why?
|
beta-Lactamases | 1 | 2024 | 308 | 0.200 |
Why?
|
Spores, Fungal | 1 | 2021 | 89 | 0.190 |
Why?
|
Graphite | 1 | 2021 | 77 | 0.180 |
Why?
|
Surgical Wound Infection | 1 | 2010 | 1547 | 0.180 |
Why?
|
Luminescence | 2 | 2013 | 108 | 0.180 |
Why?
|
Curcumin | 1 | 2021 | 97 | 0.180 |
Why?
|
Plankton | 1 | 2020 | 21 | 0.170 |
Why?
|
Quantum Dots | 1 | 2021 | 166 | 0.170 |
Why?
|
Sodium Azide | 1 | 2019 | 24 | 0.170 |
Why?
|
Abetalipoproteinemia | 1 | 2019 | 16 | 0.170 |
Why?
|
Skin Diseases | 2 | 2006 | 1084 | 0.160 |
Why?
|
Physical Phenomena | 1 | 2019 | 48 | 0.160 |
Why?
|
Humans | 48 | 2023 | 766766 | 0.160 |
Why?
|
Polyethyleneimine | 2 | 2010 | 70 | 0.160 |
Why?
|
Arthritis, Infectious | 2 | 2013 | 347 | 0.160 |
Why?
|
Drug Delivery Systems | 3 | 2023 | 2210 | 0.160 |
Why?
|
Female | 29 | 2020 | 396520 | 0.150 |
Why?
|
Cryosurgery | 1 | 2003 | 478 | 0.140 |
Why?
|
Dermatologic Agents | 1 | 2021 | 314 | 0.140 |
Why?
|
Decontamination | 2 | 2019 | 73 | 0.140 |
Why?
|
Luminescent Measurements | 2 | 2016 | 342 | 0.140 |
Why?
|
Serial Passage | 1 | 2016 | 23 | 0.130 |
Why?
|
Models, Biological | 3 | 2010 | 9461 | 0.130 |
Why?
|
Sampling Studies | 1 | 2017 | 614 | 0.130 |
Why?
|
Iodides | 1 | 2015 | 39 | 0.120 |
Why?
|
DNA Damage | 3 | 2017 | 2467 | 0.120 |
Why?
|
Nanoparticles | 2 | 2022 | 1966 | 0.120 |
Why?
|
Electric Stimulation Therapy | 1 | 2020 | 635 | 0.120 |
Why?
|
Shoulder Joint | 1 | 2021 | 745 | 0.120 |
Why?
|
Docosahexaenoic Acids | 1 | 2020 | 915 | 0.110 |
Why?
|
Vagina | 1 | 2019 | 849 | 0.110 |
Why?
|
Gram-Positive Bacteria | 2 | 2011 | 180 | 0.110 |
Why?
|
Treatment Outcome | 9 | 2020 | 65273 | 0.100 |
Why?
|
Bacillus megaterium | 1 | 2012 | 19 | 0.100 |
Why?
|
Bacillus cereus | 1 | 2012 | 36 | 0.100 |
Why?
|
Gram-Negative Bacteria | 2 | 2011 | 276 | 0.100 |
Why?
|
Cross Infection | 1 | 2021 | 1427 | 0.100 |
Why?
|
Oxazolidinones | 1 | 2013 | 99 | 0.100 |
Why?
|
Chromatography, High Pressure Liquid | 1 | 2016 | 1528 | 0.100 |
Why?
|
In Situ Nick-End Labeling | 1 | 2012 | 610 | 0.100 |
Why?
|
Fatty Acids | 1 | 2019 | 1806 | 0.090 |
Why?
|
Shock, Traumatic | 1 | 2011 | 22 | 0.090 |
Why?
|
Acetamides | 1 | 2013 | 260 | 0.090 |
Why?
|
Benzylidene Compounds | 1 | 2011 | 25 | 0.090 |
Why?
|
Chaperonin 60 | 1 | 2011 | 97 | 0.090 |
Why?
|
Brain Injuries | 2 | 2013 | 2053 | 0.090 |
Why?
|
Chlorophyllides | 1 | 2010 | 54 | 0.090 |
Why?
|
Photobleaching | 1 | 2010 | 29 | 0.090 |
Why?
|
Oxidative Stress | 2 | 2019 | 3139 | 0.090 |
Why?
|
Peritoneum | 1 | 2011 | 227 | 0.090 |
Why?
|
Drug Compounding | 1 | 2011 | 236 | 0.080 |
Why?
|
Heat-Shock Response | 1 | 2011 | 179 | 0.080 |
Why?
|
Aerosol Propellants | 2 | 2006 | 8 | 0.080 |
Why?
|
Sensitivity and Specificity | 2 | 2017 | 14652 | 0.080 |
Why?
|
Vancomycin | 1 | 2013 | 504 | 0.080 |
Why?
|
Acetates | 1 | 2011 | 314 | 0.080 |
Why?
|
Guinea Pigs | 1 | 2011 | 1309 | 0.080 |
Why?
|
Bacteroides fragilis | 1 | 2011 | 250 | 0.080 |
Why?
|
Skin, Artificial | 1 | 2010 | 89 | 0.080 |
Why?
|
Microscopy, Electron | 1 | 2013 | 2551 | 0.080 |
Why?
|
Postoperative Complications | 2 | 2011 | 15831 | 0.080 |
Why?
|
Proteus Infections | 1 | 2008 | 10 | 0.080 |
Why?
|
Melanosis | 1 | 2010 | 93 | 0.080 |
Why?
|
Organometallic Compounds | 1 | 2012 | 647 | 0.080 |
Why?
|
Prodrugs | 1 | 2011 | 274 | 0.080 |
Why?
|
Community-Acquired Infections | 1 | 2013 | 470 | 0.080 |
Why?
|
Blood Platelets | 1 | 2019 | 2465 | 0.080 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2021 | 10745 | 0.080 |
Why?
|
HSP70 Heat-Shock Proteins | 1 | 2011 | 393 | 0.080 |
Why?
|
Hoof and Claw | 1 | 2008 | 12 | 0.080 |
Why?
|
Dimethyl Sulfoxide | 1 | 2009 | 250 | 0.080 |
Why?
|
Random Allocation | 1 | 2012 | 2394 | 0.070 |
Why?
|
Hypertrichosis | 1 | 2007 | 31 | 0.070 |
Why?
|
Iodine | 1 | 2010 | 285 | 0.070 |
Why?
|
Administration, Cutaneous | 1 | 2010 | 712 | 0.070 |
Why?
|
Delayed-Action Preparations | 1 | 2011 | 966 | 0.070 |
Why?
|
Epithelial Cells | 1 | 2019 | 3691 | 0.070 |
Why?
|
Wounds and Injuries | 1 | 2020 | 2513 | 0.070 |
Why?
|
Staphylococcus aureus | 2 | 2012 | 1429 | 0.070 |
Why?
|
Drug Carriers | 1 | 2011 | 702 | 0.070 |
Why?
|
Metal Nanoparticles | 1 | 2011 | 398 | 0.070 |
Why?
|
Sus scrofa | 1 | 2008 | 431 | 0.070 |
Why?
|
Rats | 3 | 2011 | 23717 | 0.070 |
Why?
|
Neurogenesis | 1 | 2013 | 862 | 0.070 |
Why?
|
Dogs | 1 | 2011 | 3834 | 0.070 |
Why?
|
Skin Temperature | 1 | 2006 | 96 | 0.060 |
Why?
|
Cell Line | 1 | 2020 | 15563 | 0.060 |
Why?
|
Nails | 1 | 2008 | 299 | 0.060 |
Why?
|
Thigh | 1 | 2007 | 236 | 0.060 |
Why?
|
Cells, Cultured | 2 | 2012 | 18984 | 0.060 |
Why?
|
Linear Models | 1 | 2016 | 5874 | 0.060 |
Why?
|
Nevus, Pigmented | 1 | 2007 | 222 | 0.060 |
Why?
|
Neutrophils | 3 | 2013 | 3782 | 0.060 |
Why?
|
Cicatrix, Hypertrophic | 1 | 2006 | 80 | 0.060 |
Why?
|
Indoles | 1 | 2012 | 1834 | 0.060 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2011 | 1657 | 0.060 |
Why?
|
Escherichia coli Proteins | 1 | 2011 | 1055 | 0.060 |
Why?
|
Inflammation | 2 | 2020 | 10860 | 0.060 |
Why?
|
Regeneration | 1 | 2012 | 1520 | 0.050 |
Why?
|
Colon | 1 | 2011 | 1797 | 0.050 |
Why?
|
Cell Survival | 1 | 2012 | 5748 | 0.050 |
Why?
|
Aerosols | 1 | 2005 | 634 | 0.050 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3110 | 0.050 |
Why?
|
Therapy, Computer-Assisted | 1 | 2004 | 265 | 0.050 |
Why?
|
Radiotherapy Dosage | 2 | 2011 | 2911 | 0.050 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3232 | 0.050 |
Why?
|
Hyperthermia, Induced | 1 | 2006 | 414 | 0.050 |
Why?
|
Arthritis | 1 | 2007 | 684 | 0.050 |
Why?
|
Benzoyl Peroxide | 1 | 2021 | 22 | 0.050 |
Why?
|
Up-Regulation | 3 | 2019 | 4142 | 0.050 |
Why?
|
Apoptosis | 2 | 2016 | 9513 | 0.050 |
Why?
|
Body Temperature | 1 | 2004 | 780 | 0.050 |
Why?
|
Dentistry | 1 | 2021 | 117 | 0.050 |
Why?
|
Swine | 1 | 2011 | 5987 | 0.050 |
Why?
|
Trauma Severity Indices | 1 | 2003 | 479 | 0.050 |
Why?
|
Electrophoresis, Gel, Pulsed-Field | 1 | 2020 | 142 | 0.050 |
Why?
|
Mice, Inbred C57BL | 2 | 2017 | 22352 | 0.040 |
Why?
|
Chlorhexidine | 1 | 2021 | 159 | 0.040 |
Why?
|
Immunity, Innate | 1 | 2012 | 3077 | 0.040 |
Why?
|
Solubility | 2 | 2012 | 1078 | 0.040 |
Why?
|
Cell Wall | 1 | 2022 | 419 | 0.040 |
Why?
|
Colonic Neoplasms | 1 | 2011 | 2534 | 0.040 |
Why?
|
Models, Animal | 1 | 2005 | 2121 | 0.040 |
Why?
|
Radiation Injuries | 1 | 2006 | 1194 | 0.040 |
Why?
|
Blood Preservation | 1 | 2019 | 169 | 0.040 |
Why?
|
Tachycardia | 1 | 2020 | 598 | 0.040 |
Why?
|
Lasers, Solid-State | 1 | 2020 | 183 | 0.040 |
Why?
|
Pneumonia, Bacterial | 1 | 2020 | 319 | 0.040 |
Why?
|
Follow-Up Studies | 2 | 2017 | 39309 | 0.040 |
Why?
|
Gene Expression Profiling | 1 | 2012 | 9525 | 0.030 |
Why?
|
Survival Analysis | 1 | 2008 | 10100 | 0.030 |
Why?
|
Genes, Bacterial | 1 | 2019 | 1076 | 0.030 |
Why?
|
Nanostructures | 1 | 2020 | 549 | 0.030 |
Why?
|
Fluorescent Dyes | 2 | 2013 | 1927 | 0.030 |
Why?
|
Tetrapyrroles | 1 | 2013 | 3 | 0.030 |
Why?
|
Consensus | 1 | 2024 | 3208 | 0.030 |
Why?
|
Adenocarcinoma | 1 | 2011 | 6359 | 0.030 |
Why?
|
Keratin-14 | 1 | 2013 | 57 | 0.030 |
Why?
|
Neurons | 1 | 2013 | 9515 | 0.030 |
Why?
|
Drug Antagonism | 1 | 2013 | 50 | 0.030 |
Why?
|
Joint Capsule | 1 | 2013 | 68 | 0.030 |
Why?
|
Fluoresceins | 1 | 2013 | 235 | 0.030 |
Why?
|
Optical Phenomena | 1 | 2013 | 103 | 0.030 |
Why?
|
Photochemical Processes | 1 | 2012 | 84 | 0.030 |
Why?
|
Bromodeoxyuridine | 1 | 2013 | 310 | 0.030 |
Why?
|
Free Radicals | 1 | 2012 | 237 | 0.030 |
Why?
|
Proliferating Cell Nuclear Antigen | 1 | 2013 | 284 | 0.020 |
Why?
|
Electron Transport | 1 | 2012 | 211 | 0.020 |
Why?
|
Injections, Intra-Articular | 1 | 2013 | 284 | 0.020 |
Why?
|
Stomach Ulcer | 1 | 2011 | 118 | 0.020 |
Why?
|
Computer Simulation | 1 | 2004 | 6259 | 0.020 |
Why?
|
Pandemics | 2 | 2021 | 8735 | 0.020 |
Why?
|
Injections, Intraperitoneal | 1 | 2011 | 410 | 0.020 |
Why?
|
Arthritis, Experimental | 1 | 2013 | 293 | 0.020 |
Why?
|
Micelles | 1 | 2011 | 190 | 0.020 |
Why?
|
Cations | 1 | 2010 | 239 | 0.020 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2020 | 3511 | 0.020 |
Why?
|
Candida | 1 | 2010 | 174 | 0.020 |
Why?
|
Pyrrolidines | 1 | 2011 | 339 | 0.020 |
Why?
|
Signal Transduction | 1 | 2012 | 23619 | 0.020 |
Why?
|
Male | 10 | 2021 | 364142 | 0.020 |
Why?
|
Skin Neoplasms | 1 | 2007 | 5861 | 0.020 |
Why?
|
Dental Caries | 1 | 2011 | 429 | 0.020 |
Why?
|
Virus Diseases | 1 | 2013 | 720 | 0.020 |
Why?
|
Zymosan | 1 | 2007 | 134 | 0.020 |
Why?
|
Cell Proliferation | 2 | 2013 | 10445 | 0.020 |
Why?
|
Sepsis | 1 | 2020 | 2604 | 0.020 |
Why?
|
Species Specificity | 1 | 2011 | 2413 | 0.020 |
Why?
|
HeLa Cells | 1 | 2012 | 3073 | 0.020 |
Why?
|
Periodontitis | 1 | 2011 | 576 | 0.020 |
Why?
|
Erythema | 1 | 2007 | 261 | 0.020 |
Why?
|
Water | 1 | 2012 | 1417 | 0.020 |
Why?
|
Drug Design | 1 | 2011 | 1042 | 0.020 |
Why?
|
Rats, Inbred Lew | 1 | 2007 | 1168 | 0.020 |
Why?
|
Pigmentation | 1 | 2006 | 143 | 0.020 |
Why?
|
Adenosine Triphosphate | 1 | 2011 | 2001 | 0.020 |
Why?
|
Time Factors | 2 | 2007 | 40149 | 0.020 |
Why?
|
Structure-Activity Relationship | 1 | 2010 | 3053 | 0.020 |
Why?
|
Fibrosis | 1 | 2012 | 2077 | 0.020 |
Why?
|
Down-Regulation | 1 | 2012 | 2931 | 0.020 |
Why?
|
Abdomen | 1 | 2011 | 1137 | 0.010 |
Why?
|
Behavior, Animal | 1 | 2013 | 1865 | 0.010 |
Why?
|
Dinoprostone | 1 | 2007 | 597 | 0.010 |
Why?
|
Face | 1 | 2010 | 1029 | 0.010 |
Why?
|
Gene Regulatory Networks | 1 | 2012 | 1751 | 0.010 |
Why?
|
Edema | 1 | 2007 | 764 | 0.010 |
Why?
|
Drug Therapy, Combination | 1 | 2013 | 6307 | 0.010 |
Why?
|
Motor Activity | 1 | 2013 | 2711 | 0.010 |
Why?
|
Adult | 4 | 2021 | 223307 | 0.010 |
Why?
|
Combined Modality Therapy | 1 | 2013 | 8540 | 0.010 |
Why?
|
Neck | 1 | 2006 | 735 | 0.010 |
Why?
|
Middle Aged | 5 | 2010 | 223257 | 0.010 |
Why?
|
Atrophy | 1 | 2006 | 1631 | 0.010 |
Why?
|
Polysaccharides | 1 | 2007 | 1020 | 0.010 |
Why?
|
Hypothermia, Induced | 1 | 2005 | 754 | 0.010 |
Why?
|
Dexamethasone | 1 | 2007 | 1962 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2013 | 11061 | 0.010 |
Why?
|
Papillomavirus Infections | 1 | 2011 | 1639 | 0.010 |
Why?
|
Blood Coagulation | 1 | 2005 | 1163 | 0.010 |
Why?
|
Cytokines | 1 | 2013 | 7438 | 0.010 |
Why?
|
Anti-Inflammatory Agents | 1 | 2007 | 1805 | 0.010 |
Why?
|
RNA, Messenger | 1 | 2012 | 12791 | 0.010 |
Why?
|
Research Design | 1 | 2013 | 6207 | 0.010 |
Why?
|
Cell Line, Tumor | 1 | 2011 | 17088 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2012 | 20144 | 0.010 |
Why?
|
United States | 1 | 2021 | 72951 | 0.010 |
Why?
|
Depression | 1 | 2011 | 8228 | 0.010 |
Why?
|
Aged | 1 | 2003 | 171343 | 0.010 |
Why?
|
Brain | 1 | 2011 | 27159 | 0.000 |
Why?
|
Adolescent | 1 | 2007 | 88904 | 0.000 |
Why?
|